Boothbay Fund Management »

Aquestive Therapeutics shares owned by Boothbay Fund Management

Quarter-by-quarter ownership of Aquestive Therapeutics (AQST) shares owned by Boothbay Fund Management from 13F filings

Historical chart of Boothbay Fund Management investment in Aquestive Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aquestive Therapeutics held by Boothbay Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aquestive Therapeutics by Boothbay Fund Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $888k 138k 6.46
2019-12-31 $483k 83k 5.82

More positions owned by Boothbay Fund Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation (NVDA)
Tesla Motors (TSLA)
Amazon Put Option (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Palantir Technologies Cl A Put Option (PLTR)
Abivax Sa Sponsored Ads (ABVX)
Alphabet Cap Stk Cl C Put Option (GOOG)
Mineralys Therapeutics Put Option (MLYS)
Advanced Micro Devices (AMD)
Microsoft Corporation (MSFT)
Invesco Exch Traded Fd Tr Ii S&p Midcp Low Call Option (XMLV)
Spdr Gold Tr Gold Shs Put Option (GLD)
Apple (AAPL)

View all positions for Boothbay Fund Management

Top funds holding Aquestive Therapeutics

Bratton Capital Management
BlackRock
Rtw Investments
Vanguard Group
Perceptive Advisors
EcoR1 Capital
Samsara BioCapital
State Street Corporation
Geode Capital Management
Federated Investors
Sio Capital Management
Millennium Management
Susquehanna International
Wells Fargo & Company
Bnp Paribas Arbitrage, Snc

View all funds holding Aquestive Therapeutics